use
standard
cultur
andor
molecular
approach
quantit
differ
among
intestin
microbiota
speci
extens
studi
alter
intestin
microbiota
patient
chronic
constip
character
rel
decreas
oblig
bacteria
eg
lactobacillu
bifidobacterium
bacteroid
spp
parallel
increas
potenti
pathogen
microorgan
eg
pseudomona
aeruginosa
campylobact
jejuni
gerritsen
et
al
kirgizov
et
al
alter
may
influenc
intestin
motil
secretori
function
chang
amount
avail
physiolog
activ
substanc
metabol
environ
gut
khalif
et
al
report
level
bifidobacteria
lactobacillu
significantli
decreas
adult
patient
constip
khalif
et
al
patient
constip
predominantirrit
bowel
syndrom
ibsc
exhibit
signific
increas
bacteroid
sp
enterobacteriacea
simren
et
al
concentr
bifidobacteria
clostridium
leptum
faecalibacterium
prausnitzii
decreas
patient
ibsc
nourrisson
et
al
meanwhil
one
pediatr
studi
indic
clostridia
bifidobacteria
significantli
increas
fece
constip
children
besid
clostridium
speci
isol
constip
children
differ
healthi
control
zoppi
et
al
use
rrna
gene
pyrosequenc
method
zhu
et
al
observ
significantli
decreas
abund
prevotella
increas
represent
sever
genera
firmicut
constip
patient
compar
control
zhu
et
al
butyrateproduc
genera
coprococcu
roseburia
faecalibacterium
tend
increas
constip
patient
pryde
et
al
sokol
et
al
studi
indic
constip
could
consequ
intestin
dysbiosi
noteworthi
discord
report
detect
microbiota
alter
among
patient
constip
discrep
may
result
differ
method
use
bacteri
quantif
use
singl
sampl
factor
eg
diet
phenotyp
character
patient
simren
et
al
furthermor
studi
assess
fecal
microbiota
readili
access
fulli
replic
profil
mucos
microbiota
patient
constip
mucos
microbiota
might
affect
epitheli
mucos
function
greater
degre
fecal
microbiota
durban
et
al
park
et
al
one
recent
studi
report
overal
composit
colon
mucos
microbiota
associ
constip
genera
bacteroidet
abund
colon
mucos
microbiota
patient
constip
meanwhil
profil
fecal
microbiota
associ
colon
transit
methan
product
constip
parthasarathi
et
al
studi
detail
higher
resolut
mucos
fecal
microbiota
composit
might
expand
understand
relationship
intestin
microbiota
constip
though
wide
use
cultur
andor
molecular
approach
could
assess
function
imbal
intestin
microbiota
patient
constip
therebi
functionbas
approach
base
detect
specif
metabol
activ
express
group
bacteri
speci
put
forward
recent
studi
chassard
et
al
show
ibsc
microbiota
character
high
number
lactat
sulphatereduc
bacteria
compar
healthi
control
could
turn
influenc
colon
motil
viscer
sensit
gener
ib
symptom
chassard
et
al
due
chang
metabol
output
function
dysbiosi
might
import
clinic
implic
provid
new
dimens
manag
chronic
constip
knowledg
effect
intestin
microbiota
gut
motil
deriv
studi
germfre
anim
germfre
rat
exhibit
longer
migrat
myoelectr
complex
mmc
interv
compar
convent
rat
caenepeel
et
al
cecum
germfre
rat
enlarg
gastric
empti
colon
transit
delay
abram
studi
colon
convent
intestin
microbiota
germfre
rat
reveal
lactobacillu
acidophilu
bifidobacterium
bifidum
could
reduc
mmc
period
acceler
small
intestin
transit
micrococcu
luteu
escherichia
coli
show
inhibitori
effect
huseby
et
al
barbara
et
al
put
forward
three
mechan
respons
effect
microbiota
intestin
motil
barbara
et
al
releas
bacteri
substanc
endproduct
bacteri
ferment
intestin
neuroendocrin
factor
mediat
releas
gut
immun
respons
bacteri
endotoxin
lipopolysaccharid
may
influenc
intestin
motil
delay
gastric
empti
induc
sphincter
dysfunct
fan
et
al
deconjug
bile
salt
kind
bacteri
metabolit
may
promot
colon
motor
respons
induc
bile
salt
relat
diarrhea
floch
shortchain
fatti
acid
scfa
butyr
acet
propion
produc
colon
anaerob
bacteri
metabol
carbohydr
scfa
shown
stimul
ileal
propuls
contract
evok
prolong
propag
contract
discret
cluster
contract
possibl
mechan
scfa
gut
motil
may
involv
intestin
releas
addit
scfa
could
directli
stimul
ileal
colon
smooth
muscl
contractil
lactat
quickli
metabol
specif
bacteri
speci
butyr
propion
high
concentr
butyr
may
inhibit
mucin
secret
intestin
goblet
cell
baxter
et
al
studi
indic
butyr
may
reduc
stool
volum
stimul
water
electrolyt
absorpt
colon
canani
et
al
number
lactateutilis
bacteria
obvious
decreas
tenfold
faecal
microbiota
ibsc
patient
rajilicstojanov
et
al
human
colon
gase
produc
microflora
may
also
associ
chang
gut
motil
exampl
breath
methan
excret
patient
slowtransit
constip
greater
healthi
subject
patient
normaltransit
constip
support
idea
methan
slow
gut
transit
attaluri
et
al
howev
recent
studi
report
methan
product
associ
composit
fecal
microbiota
constip
colon
transit
parthasarathi
et
al
meanwhil
accumul
postul
account
symptom
bloat
pain
pimentel
et
al
colon
demonstr
modul
peripher
painrel
signal
may
ultim
influenc
gut
sensorymotor
function
kawabata
et
al
cellenvelopeassoci
multiprotein
system
term
starch
util
system
su
present
bacteroid
speci
bacteroid
thetaiotaomicron
lammert
van
bueren
et
al
increas
number
bacteroid
speci
may
associ
product
organ
acid
excess
via
ferment
may
contribut
symptom
abdomin
distens
small
intestin
bacteri
overgrowth
sibo
condit
involv
abnorm
growth
endogen
bacteria
small
intestin
resembl
normal
found
colon
clinic
manifest
sibo
wide
rang
includ
abdomin
discomfort
bloat
diarrhea
weight
loss
nutrit
defici
gabrielli
et
al
due
inher
difficulti
measur
small
bowel
motil
studi
illustr
direct
relationship
impair
small
intestin
motil
sibo
roland
et
al
recent
report
patient
undergo
wireless
motil
capsul
sibo
signific
delay
small
bowel
transit
time
compar
without
futur
prospect
studi
need
character
sibo
contribut
pathophysiolog
mechan
small
bowel
dysmotil
hypothes
intestin
microbiota
could
modul
gut
motil
releas
neuroendocrin
factor
instanc
presenc
somatostatin
firstli
clarifi
bacillu
subtili
lenard
germfre
rat
increas
gastrin
serotonin
motilinimmunoreact
cell
select
area
gastrointestin
mucosa
neuropeptid
inhibitori
neuropeptid
found
decreas
blood
concentr
introduct
convent
intestin
microbiota
rat
huseby
et
al
find
indirectli
demonstr
intestin
microbiota
could
regul
endocrin
cell
ultim
influenc
gut
motil
besid
effect
microbiotaderiv
scfa
colon
serotonin
motilincontain
enteroendocrin
cell
also
propos
regul
colon
physiolog
immunocompet
host
commens
colon
microbiota
major
determin
mucos
system
immun
exampl
bacteroid
fragili
mediat
develop
treg
cell
activ
tolllik
receptor
tlr
nutsch
hsieh
clostridium
speci
induc
treg
cell
induct
transform
growth
ivanov
littman
mediat
releas
colon
immun
cell
known
modul
variou
digest
function
increas
express
tumor
necrosi
factor
demonstr
coliti
rat
model
could
caus
pronounc
suppress
synthesi
releas
acetylcholin
noradrenalin
collin
synergist
interact
confirm
pharmacolog
electrophysiolog
atanasova
et
al
similar
observ
drawn
respect
role
suppress
noradrenalin
releas
sullivan
et
al
clostridi
speci
polysaccharid
deriv
bacteroidet
speci
strain
induc
product
promot
tregulatori
cell
develop
suszko
obminskamrukowicz
segment
filament
bacteria
candidatu
svagella
requir
differenti
helper
cell
induc
lumin
secret
iga
ivanov
littman
disrupt
colon
immun
result
abnorm
respons
lumin
content
mechan
suspect
compon
develop
colon
motil
disord
dietari
fibr
recommend
empir
basi
manag
chronic
constip
known
dietari
fibr
promot
excret
intestin
mucin
stimul
capac
mucos
protein
synthesi
derrien
et
al
dietari
fibr
broken
proxim
colon
provid
energi
yield
substrat
microbi
ferment
result
stimul
growth
intestin
microbiota
contribut
significantli
stool
dri
weight
besid
fibr
could
promot
excret
bacteri
ferment
product
scfa
promotil
effect
jen
et
al
dietari
fibr
also
import
sourc
ga
colon
hydrogen
methan
carbon
dioxid
princip
end
product
bacteri
ferment
increas
stool
bulk
promot
colon
transit
lopez
roman
et
al
evid
indic
dietari
fibr
wheat
bran
pea
fibr
modul
intestin
microbiota
includ
stimul
benefici
bacteri
speci
suppress
pathogen
bacteri
speci
chen
et
al
prebiot
nondigest
substanc
provid
benefici
physiolog
effect
host
select
stimul
growth
activ
limit
number
favour
indigen
gut
bacteria
prebiot
stimul
preferenti
growth
limit
number
healthpromot
commens
flora
alreadi
resid
colon
lactobacilli
bifidobacteria
exampl
prebiot
includ
fructooligosaccharid
galactooligosaccharid
inulin
fibr
fibr
supplement
employ
treatment
constip
also
exert
prebiot
effect
bouhnik
et
al
prebiot
subject
bacteri
metabol
colon
transform
lactic
shortchain
carboxyl
acid
demonstr
galactooligosaccharid
seem
promot
intestin
peristalsi
reliev
constip
li
et
al
consumpt
inulintyp
fructan
affect
intestin
microbiota
stimul
bowel
movement
normal
stool
frequenc
constip
patient
quigley
noteworthi
evid
regard
benefici
effect
prebiot
constip
deriv
anim
studi
human
trial
conduct
small
number
constip
subject
tabl
howev
one
recent
trial
prebiot
sixti
constip
women
report
signific
differ
satisfact
relief
constip
prebiot
group
placebo
group
linetzki
waitzberg
et
al
adequ
power
studi
need
carri
draw
definit
conclus
probiot
live
attenu
microorgan
defin
capabl
confer
health
benefit
host
given
suffici
quantiti
administ
continu
beyond
inher
nutrit
valu
probiot
demonstr
benefici
effect
patient
constip
make
increasingli
use
alter
treatment
option
tabl
recent
systemat
review
probiot
treatment
chronic
constip
demonstr
probiot
lead
signific
improv
mean
number
stool
per
week
dimidi
et
al
sever
mechan
propos
probiot
may
benefit
chronic
constip
probiot
may
modifi
alter
intestin
microbiota
patient
constip
probiot
metabolit
may
alter
gut
sensat
motil
function
waller
et
al
probiot
may
regul
intralumin
environ
increas
end
product
bacteri
ferment
reduc
lumin
ph
waller
et
al
etc
bifidobacteria
lactobacilli
gener
recogn
benefici
speci
variou
healthpromot
function
product
scfa
stimul
intestin
peristalsi
increas
humid
fecal
bolu
ojetti
et
al
larg
random
control
trial
demonstr
intak
effect
amount
lactobacillu
plantarum
bifidobacterium
breve
bifidobacterium
lacti
abl
significantli
reliev
evacu
disord
hard
stool
patient
constip
del
piano
et
al
supplement
lactobacillu
casei
shirota
could
significantli
increas
frequenc
defec
soft
stool
ibsc
patient
koebnick
et
al
posit
effect
lactobacillu
reuteri
bowel
movement
frequenc
confirm
adult
children
patient
constip
wu
et
al
evid
show
l
reuteri
could
promot
frequenc
veloc
colon
myoelectr
motil
complex
barbara
et
al
one
vitro
studi
indic
escherichia
coli
nissl
supernat
could
enhanc
colon
contractil
direct
stimul
smooth
muscl
cell
bar
et
al
probiot
bifidobacterium
lacti
bifidobacterium
longum
could
modifi
metabol
activ
colon
microbiota
improv
lactos
digest
chines
lactoseintoler
subject
et
al
children
lactobacillu
casei
rhamnosu
show
favor
effect
reliev
symptom
constip
bu
et
al
combin
probiot
prebiot
name
synbiot
may
provid
synergist
effect
synbiot
administr
may
improv
surviv
probiot
restor
intestin
microbi
balanc
may
posit
effect
treatment
constip
khodadad
sabbaghian
metaanalysi
conduct
alexand
c
ford
report
synbiot
appear
effect
placebo
chronic
constip
number
need
treat
nnt
synbiot
chronic
constip
ci
ford
et
al
probiot
wide
use
nowaday
treatment
constip
howev
concern
safeti
probiot
still
warrant
discuss
probiot
administr
may
modul
composit
intestin
microbiota
consequ
induc
alter
metabol
activ
colon
immunolog
activ
dai
et
al
besid
probiot
administr
may
transfer
antimicrobi
resist
gene
normal
intestin
flora
pathogen
speci
drago
et
al
fecal
microbiota
transplant
fmt
also
known
fecal
bacteriotherapi
fecal
infus
refer
process
transplant
function
flora
stool
healthi
donor
gastrointestin
tract
recipi
individu
propos
therapeut
approach
chronic
constip
reestablish
wide
divers
intestin
flora
exampl
one
patient
report
andrew
et
al
develop
constip
receiv
fmt
therapi
two
three
day
follow
therapi
patient
stool
frequenc
increas
per
day
without
laxativeus
borodi
et
al
borodi
et
al
administ
fmt
patient
chronic
constip
patient
experienc
immedi
resolut
symptom
constip
stool
per
day
accompani
resolut
associ
symptom
episod
nausea
vomit
bloat
abdomin
pain
improv
persist
month
followup
borodi
et
al
li
et
al
treat
patient
slow
transit
constip
stc
mean
fmt
patient
stool
frequenc
increas
mean
sd
per
week
sd
week
postfmt
compar
baselin
signific
overal
improv
seen
gastrointestin
qualityoflif
index
score
week
followup
tian
et
al
though
publish
report
fmt
number
consist
small
uncontrol
open
studi
case
report
therapeut
benefit
fmt
treatment
constip
suggest
potenti
inexpens
safe
treatment
modal
undergo
investig
clinic
use
collect
alter
intestin
microbiota
may
play
essenti
role
pathogenesi
chronic
constip
howev
precis
mechan
intestin
microbiota
regul
gut
sensori
motor
function
still
partli
unclear
futur
research
identifi
precis
intestin
microbiota
particip
modul
gut
physiolog
pathophysiolog
benefici
understand
interact
intestin
microbiota
gut
function
also
invalu
ultim
develop
new
therapeut
tool
manag
chronic
constip
